{"id":97757,"date":"2026-04-23T00:12:10","date_gmt":"2026-04-23T00:12:10","guid":{"rendered":"https:\/\/mybusinessfuture.com\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/"},"modified":"2026-06-10T14:38:13","modified_gmt":"2026-06-10T14:38:13","slug":"1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe","status":"publish","type":"post","link":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/","title":{"rendered":"AI-Powered Medical Devices Surge in U.S. \u2013 Europe Lags"},"content":{"rendered":"<p><span style=\"background:#c0392b;color:#fff;font-size:11px;font-weight:700;padding:3px 10px;border-radius:3px;letter-spacing:0.5px;text-transform:uppercase;\">10 Min. Reading Time<\/span><\/p>\n<p style=\"display:inline-block;background:#c0392b;color:#fff;padding:4px 14px;border-radius:20px;font-size:0.85em;margin-bottom:18px;\">5 min de lecture<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\"><strong>The US Food and Drug Administration (FDA) approved exactly 1,451 medical devices based on artificial intelligence by the end of 2025 \u2013 295 of which were approved in 2025 alone. In Europe, there is no comparable public database. While American clinics deploy diagnostic tools based on AI daily, German hospitals use isolated solutions and are waiting for the EU&#8217;s Artificial Intelligence Act (AI Act) to come into effect, the requirements for high-risk systems not taking effect until 2027. A status update.<\/strong><\/p>\n<div style=\"background:#fafafa;border-left:4px solid #c0392b;padding:20px 24px;margin:32px 0;border-radius:0 8px 8px 0\">\n<h2 style=\"margin-top:0;margin-bottom:12px;\">Key Takeaways<\/h2>\n<ul>\n<li><strong>1,451 AI-based medical devices authorized in the US:<\/strong> 295 in 2025 alone, 76% related to radiology. GE HealthCare dominates the ranking with 120 approvals (The Imaging Wire, March 2026).<\/li>\n<li><strong>No European tracking:<\/strong> There is no public database listing CE-marked AI-based medical devices. At least 219 such devices are estimated to be on the market (data from January 2025).<\/li>\n<li><strong>Only 2.4% validated by randomized trial:<\/strong> Of the 903 AI-based medical devices examined by the FDA, 24.1% had no clinical study. Only 2.4% had been subject to a randomized controlled trial (JAMA Network Open, 2025).<\/li>\n<li><strong>DACH clinics already deploying AI:<\/strong> Asklepios uses Aidoc in over 25 facilities; the Vara-PRAIM study increased breast cancer detection by 17.6% in 463,094 women.<\/li>\n<li><strong>High-risk AI Act deadline: August 2027.<\/strong> Until then, medical AI systems will have to fully meet requirements for risk management, data quality, and human oversight.<\/li>\n<\/ul>\n<\/div>\n<h2 style=\"padding-top:64px;margin-bottom:20px;\">295 Authorizations in One Year: What the FDA Numbers Reveal<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Since 2017, the FDA has maintained a public database listing all medical devices based on AI that have received market authorization. These numbers reveal a clear trend: from 29 authorizations in 2017 to 295 in 2025 \u2013 a record that significantly surpasses the previous one, set the previous year at 223.<\/p>\n<div class=\"evm-stat evm-stat-highlight\" style=\"text-align:center;background:#fff5f5;border-radius:12px;padding:32px 24px;margin:32px 0;\">\n<div style=\"font-size:clamp(1.5em,5vw,2.4em);font-weight:700;color:#c0392b;letter-spacing:-0.03em;\">1,451<\/div>\n<div style=\"font-size:15px;color:#444;margin-top:8px;\">AI-based Medical Devices Authorized by the FDA (cumulative up to the end of 2025)<\/div>\n<div style=\"font-size:12px;color:#888;margin-top:8px;\">Source: The Imaging Wire \/ FDA, March 2026<\/div>\n<\/div>\n<p style=\"line-height:1.8;margin-bottom:20px;\">76% of all authorized AI-based medical devices concern radiology \u2013 a field where pattern recognition from large amounts of imaging data works particularly well. GE HealthCare ranks first in the list with 120 authorizations, followed by Siemens Healthineers with 89. The fact that two of the top three manufacturers have European roots makes the regulatory asymmetry between the US and the European Union even more striking.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">However, each authorization does not automatically equate to proven clinical utility. An analysis published in <em>JAMA Network Open<\/em> (April 2025), covering 903 AI-based medical devices authorized by the FDA, arrived at a disappointing conclusion: 24.1% of them had no validation clinical studies. Only 2.4% had been tested in a randomized controlled trial, and 8.1% in a prospective trial. Approximately 90% of the devices relied on retrospective data or no clinical evidence at all.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">This means that the figure of 1,451 authorizations granted by the FDA is impressive as an indicator of market dynamics. However, it constitutes only a limited quality criterion. For hospital buyers evaluating an AI-based system, FDA authorization alone is not a sufficient criterion. What matters most are prospective studies conducted on comparable patient cohorts, as well as transparent and reproducible clinical validation in their own care context.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px;\">Europe&#8217;s Blind Spot: No Database, No Transparency<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px;\">In Europe, no comparable public list exists. Neither the European Medicines Agency (EMA) nor the German Federal Institute for Drugs and Medical Devices (BfArM) maintains a publicly accessible database of medical devices based on AI that bear the CE mark. The European database EUDAMED, intended to ensure transparency, has been under development for several years. Certain modules will become mandatory from May 2026, but a comprehensive overview of all AI-based products on the European market will only be available several years later.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Independent observers estimate that at least 219 medical devices based on AI bear the CE mark (data as of January 2025). The actual number is likely higher, but no one knows for certain. For hospital buyers faced with the question of which AI-based system to evaluate, this constitutes a concrete problem.<\/p>\n<div style=\"overflow-x:auto;margin:32px 0;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:0.95em;\">\n<thead>\n<tr style=\"background:#c0392b;color:#fff;\">\n<th style=\"padding:12px 16px;text-align:left;\">Criterion<\/th>\n<th style=\"padding:12px 16px;text-align:center;\">United States (FDA)<\/th>\n<th style=\"padding:12px 16px;text-align:center;\">Europe (CE\/MDR)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #e9ecef;\">\n<td style=\"padding:10px 16px;font-weight:600;\">Public AI Database<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">Yes, since 2017<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">No (EUDAMED under development)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef;background:#fafafa;\">\n<td style=\"padding:10px 16px;font-weight:600;\">Authorized AI-based Devices<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">1,451 (cumulative)<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">At least 219 (estimate)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef;\">\n<td style=\"padding:10px 16px;font-weight:600;\">Approval Rate in 2025<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">295 new devices<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">Unknown (no statistics)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef;background:#fafafa;\">\n<td style=\"padding:10px 16px;font-weight:600;\">Specific AI Regulation<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">FDA framework since 2021<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">AI Act from August 2027<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef;\">\n<td style=\"padding:10px 16px;font-weight:600;\">Clinical Validation<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">Mandatory, but incomplete<\/td>\n<td style=\"padding:10px 16px;text-align:center;\">Compliant with Medical Device Regulation (MDR) (more stringent)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2 style=\"padding-top:64px;margin-bottom:20px;\">DACH Clinics Deploy AI \u2013 But in Isolated Solutions<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Despite regulatory gaps at the European level, some DACH (Germany, Austria, Switzerland) clinics are already actively using AI-based diagnostic tools. The results are promising, but remain fragmented.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Asklepios, one of the largest private clinic operators in Germany, has installed the Israeli AI system Aidoc in over 25 facilities. This software analyzes CT scans in real-time to detect strokes, intracranial hemorrhages, and vertebral body fractures \u2013 funded by grants from the KHZG program. Its advantage? Aidoc prioritizes the list of imaging reports, allowing critical cases to be treated immediately by the radiologist, rather than remaining on a waiting list.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">The largest prospective study to date on the use of AI in diagnostics also comes from Germany. The Vara-PRAIM study, published in <em>Nature Medicine<\/em>, analyzed over 463,000 screening mammographies. Result: a 17.6% increase in breast cancer detection rate, accompanied by a reduction in radiologists&#8217; workload. This is the largest prospective global study of its kind.<\/p>\n<blockquote style=\"border-left:4px solid #c0392b;margin:32px 0;padding:20px 24px;background:#fafafa;border-radius:0 8px 8px 0;font-size:1.1em;line-height:1.6;color:#333;\"><p>\n&#8222;The question is no longer whether AI works in diagnostics. It&#8217;s now about how we can successfully transfer research into everyday practice \u2013 on regulatory, organizational, and economic levels.&#8220;<br \/>\n<cite style=\"display:block;margin-top:12px;font-size:0.8em;color:#888;font-style:normal;\">&#8211; Prof. Alexander Berens, University of T\u00fcbingen (press release, 2025)<\/cite>\n<\/p><\/blockquote>\n<p style=\"line-height:1.8;margin-bottom:20px;\">The problem? Each deployment is an isolated project. There is no national standard for integrating AI into hospital information systems, no standardized interface, and no central registry indicating which clinic uses which system. Although the G-BA&#8217;s Innovation Fund supports the systematic integration of AI in radiology through the xR.AI project, Germany is far from widespread deployment.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Consequence: German clinics wanting to introduce AI-based diagnostic tools must themselves pilot every step \u2013 from product selection to integration into their hospital information system (HIS), including radiologist training. Additionally, there are unresolved questions of legal liability, both nationally and at the European level. If an AI-based system misses a diagnosis and the attending physician has entirely relied on this system, who assumes responsibility? The Medical Device Regulation (MDR) governs the manufacturer&#8217;s liability, but the physician&#8217;s professional diligence remains intact. In practice, this uncertainty leads many radiologists to not use AI-provided conclusions as a decision-making basis, but at most as a simple information supplement.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px;\">The AI Act will come into effect in 2027: What MedTech companies can expect<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px;\">The EU&#8217;s general AI regulation (AI Act) came into effect in August 2024, but a transitional period applies to medical devices: the full requirements for high-risk systems will only take effect from August 2, 2027. AI-based systems classified as medical devices under the MDR or the In Vitro Diagnostic Medical Devices Regulation (IVDR) are automatically considered high-risk systems.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">What this means in practice: manufacturers will have to implement an AI-specific risk management system, comply with strict data quality and data governance requirements, produce technical documentation that goes beyond the MDR requirements, and integrate mechanisms that enable effective human oversight. The workload is considerable, especially for small companies.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">A glimmer of hope: In November 2025, the European Commission presented an omnibus proposal aimed at simplifying procedures, intended to reduce overlaps between the AI Act and the MDR\/IVDR. Instead of having to produce duplicate documentation and undergo a double conformity assessment, an integrated process is to be established. The adoption of this text is planned for summer 2026.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">For German SMEs in the MedTech sector \u2013 93% of companies in the sector have fewer than 250 employees \u2013 this issue is far from academic. In recent years, the MDR has already led some manufacturers to withdraw their products from the European market, as the costs associated with certification exceeded their revenues. If the AI Act adds a similar layer of bureaucracy, sector consolidation will continue.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">At the same time, the regulation creates a qualitative advantage: medical devices based on AI that meet both the MDR and AI Act requirements will benefit from a trust advantage compared to devices approved only by the FDA. European manufacturers that overcome these two hurdles can exploit this double label as a differentiation factor on the global market \u2013 provided they survive financially and organizationally through the transitional period until 2027.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px;\">Accelerate or fall behind<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px;\">The global AI market in healthcare was worth around $21.66 billion in 2025. It is expected to exceed $110 billion by 2030 \u2013 a compound annual growth rate of 38.6% (MarketsandMarkets). PwC Strategy estimates the European potential at $203 billion.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Germany has strong players specializing in AI applied to MedTech, such as Siemens Healthineers, Brainomix, Vara, and Merantix. Clinical research is world-class \u2013 the PRAIM study provides a striking illustration. What is lacking is the bridge between research and everyday practice: a European AI database guaranteeing transparency; a harmonized authorization process that does not crush SMEs; and a hospital landscape that views AI not as a subsidized project, but as a standard tool.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px;\">Over eight years, the FDA has authorized 1,451 AI-based medical devices, while learning to adapt its procedures. During the same period, Europe has drafted a regulation whose effects will only begin to be felt in 2027. Anyone who does not perceive this delay as a strategic risk has not understood the market dynamics.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px;\">Frequently Asked Questions<\/h2>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px;\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600;\"><strong>How many AI-based medical devices has the FDA approved up to 2025?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7;\">By the end of 2025, the FDA had approved a total of 1,451 AI-based medical devices. Only 295 were approved in 2025 \u2013 a record. 76% relate to radiology, and GE HealthCare tops the list with 120 approvals.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px;\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600;\"><strong>Is there a European database for AI-based medical devices?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7;\">No. Unlike the FDA, neither the EMA nor the BfArM maintains a public list of AI-based medical devices with CE marking. The European EUDAMED database is being deployed, with some modules becoming mandatory from May 2026. A comprehensive overview will only be available several years later.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px;\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600;\"><strong>When will the AI Act requirements apply to medical devices?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7;\">The full requirements for high-risk systems defined by the EU&#8217;s AI Act will come into effect for AI-based medical systems from August 2, 2027. Systems classified as medical devices under the MDR or IVDR are automatically considered high-risk and will have to implement AI-specific risk management and comply with strict data quality requirements.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px;\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600;\"><strong>Which German clinics are already using AI-based diagnostics?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7;\">Asklepios is deploying the AI system Aidoc in over 25 clinics for CT scan analysis (funded by the KHZG program). The Vara-PRAIM study, conducted in German breast cancer screening centers, increased the detection rate by 17.6% in 463,094 examined women. The G-BA&#8217;s xR.AI project supports the systematic integration of AI in radiology.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px;\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600;\"><strong>What is the size of the AI market in healthcare?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7;\">The global market was $21.66 billion in 2025 and is expected to exceed $110 billion by 2030 (CAGR of 38.6%, MarketsandMarkets). PwC Strategy&#038; estimates the European potential at $203 billion by 2030.<\/p>\n<\/details>\n<div class=\"evm-styled-box\" style=\"background:#fff5f5;border-radius:8px;padding:20px 24px;margin:24px 0;border-top:3px solid #c0392b;\">\n<h2 style=\"margin-top:0;margin-bottom:12px;font-size:1.05em;\">Editor&#8217;s Recommended Reads<\/h2>\n<ul>\n<li>More than one in two people consider a second opinion from &#8220;Dr. AI&#8221;<\/li>\n<li><a href=\"https:\/\/mybusinessfuture.com\/la-epa-a-lhopital-seulement-40-des-etablissements-sont-en-phase-pilote-et-des-sa\/\">Electronic Patient Record (EPR) in hospitals: only 40% of facilities are testing it \u2013 and sanctions are planned from April<\/a><\/li>\n<li><a href=\"https:\/\/mybusinessfuture.com\/en\/hospital-digitalization-synaforce-connects-care\/\">From outdated systems to connected care: how synaforce is transforming hospitals<\/a><\/li>\n<\/ul>\n<\/div>\n<p style=\"text-align:right;font-style:italic;color:#888;font-size:0.85em;\">Main image source: Pexels \/ MART PRODUCTION (px:7089623)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The US Food and Drug Administration (FDA) approved exactly 1,451 medical devices based on artificial intelligence by the end of 2025 \u2013 295 of which were approved in 2025 alone. In Europe, there is no comparable public database. While American clinics deploy diagnostic tools based on AI [&hellip;]<\/p>\n","protected":false},"author":205,"featured_media":92736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"dispositifs m\u00e9dicaux","_yoast_wpseo_title":"1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic","_yoast_wpseo_metadesc":"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","_yoast_wpseo_meta-robots-adv":"","_yoast_wpseo_canonical":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":0,"_yoast_wpseo_twitter-title":"","_yoast_wpseo_twitter-description":"","_yoast_wpseo_twitter-image":"","_yoast_wpseo_twitter-image-id":0,"featured_post_sortierung":0,"featured_post":0,"pre_headline":"","bildquelle":"","teasertext":"","language":"de","_evm_translation_lang":"","_wp_old_slug":[],"footnotes":""},"categories":[1146],"tags":[],"class_list":["post-97757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-sciences-health-care","entry"],"evm_reading_time_minutes":11,"wpml_language":"en","wpml_translation_of":94387,"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic<\/title>\n<meta name=\"description\" content=\"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic\" \/>\n<meta property=\"og:description\" content=\"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!\" \/>\n<meta property=\"og:url\" content=\"https%3A%2F%2Fmybusinessfuture.com%2Fen%2F1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe%2F\/\" \/>\n<meta property=\"og:site_name\" content=\"MyBusinessFuture\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MyBusinessFuture\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-23T00:12:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T14:38:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tobias Massow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mbusinessfuture\" \/>\n<meta name=\"twitter:site\" content=\"@mbusinessfuture\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tobias Massow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/\"},\"author\":{\"name\":\"Tobias Massow\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760\"},\"headline\":\"AI-Powered Medical Devices Surge in U.S. \u2013 Europe Lags\",\"datePublished\":\"2026-04-23T00:12:10+00:00\",\"dateModified\":\"2026-06-10T14:38:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/\"},\"wordCount\":1811,\"publisher\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg\",\"articleSection\":[\"Life Sciences &amp; Health Care\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/\",\"url\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/\",\"name\":\"1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic\",\"isPartOf\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg\",\"datePublished\":\"2026-04-23T00:12:10+00:00\",\"dateModified\":\"2026-06-10T14:38:13+00:00\",\"description\":\"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!\",\"breadcrumb\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage\",\"url\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg\",\"contentUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Digital vernetzter Klinikarbeitsplatz mit medizinischen Monitoren \u2013 Artikel zu ki-medizinprodukte und synaforce\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/mybusinessfuture.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AI-Powered Medical Devices Surge in U.S. \u2013 Europe Lags\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#website\",\"url\":\"https:\/\/mybusinessfuture.com\/en\/\",\"name\":\"MyBusinessFuture\",\"description\":\"B2B-Magazin f\u00fcr Digitalisierung, KI und Business-Innovation \u2014 Fachartikel f\u00fcr IT-Entscheider im DACH-Raum\",\"publisher\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mybusinessfuture.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#organization\",\"name\":\"MyBusinessFuture\",\"url\":\"https:\/\/mybusinessfuture.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png\",\"contentUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png\",\"width\":398,\"height\":241,\"caption\":\"MyBusinessFuture\"},\"image\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MyBusinessFuture\",\"https:\/\/x.com\/mbusinessfuture\",\"https:\/\/www.linkedin.com\/showcase\/mybusinessfuture\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760\",\"name\":\"Tobias Massow\",\"description\":\"Tobias Massow ist Gesch\u00e4ftsf\u00fchrer der Evernine Media GmbH und Herausgeber von MyBusinessFuture. Er verantwortet die strategische Ausrichtung des Magazins und des gesamten MBF Media Netzwerks mit vier B2B-Fachmagazinen f\u00fcr IT-Entscheider im deutschsprachigen Raum.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/tobias-massow\/\"],\"url\":\"https:\/\/mybusinessfuture.com\/en\/experte\/tobias-evm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic","description":"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/","og_locale":"en_US","og_type":"article","og_title":"1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic","og_description":"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!","og_url":"https%3A%2F%2Fmybusinessfuture.com%2Fen%2F1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe%2F\/","og_site_name":"MyBusinessFuture","article_publisher":"https:\/\/www.facebook.com\/MyBusinessFuture","article_published_time":"2026-04-23T00:12:10+00:00","article_modified_time":"2026-06-10T14:38:13+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg","type":"image\/jpeg"}],"author":"Tobias Massow","twitter_card":"summary_large_image","twitter_creator":"@mbusinessfuture","twitter_site":"@mbusinessfuture","twitter_misc":{"Written by":"Tobias Massow","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#article","isPartOf":{"@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/"},"author":{"name":"Tobias Massow","@id":"https:\/\/mybusinessfuture.com\/en\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760"},"headline":"AI-Powered Medical Devices Surge in U.S. \u2013 Europe Lags","datePublished":"2026-04-23T00:12:10+00:00","dateModified":"2026-06-10T14:38:13+00:00","mainEntityOfPage":{"@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/"},"wordCount":1811,"publisher":{"@id":"https:\/\/mybusinessfuture.com\/en\/#organization"},"image":{"@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg","articleSection":["Life Sciences &amp; Health Care"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/","url":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/","name":"1,451 AI-Powered Medical Devices Cleared in the U.S. \u2013 Europe Lacks Even a Basic","isPartOf":{"@id":"https:\/\/mybusinessfuture.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage"},"image":{"@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg","datePublished":"2026-04-23T00:12:10+00:00","dateModified":"2026-06-10T14:38:13+00:00","description":"Digitalization: Master AI in business. Discover the latest trends and accelerate your digital transformation today!","breadcrumb":{"@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#primaryimage","url":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg","contentUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg","width":1280,"height":853,"caption":"Digital vernetzter Klinikarbeitsplatz mit medizinischen Monitoren \u2013 Artikel zu ki-medizinprodukte und synaforce"},{"@type":"BreadcrumbList","@id":"https:\/\/mybusinessfuture.com\/en\/1-451-ai-powered-medical-devices-cleared-in-the-u-s-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/mybusinessfuture.com\/en\/"},{"@type":"ListItem","position":2,"name":"AI-Powered Medical Devices Surge in U.S. \u2013 Europe Lags"}]},{"@type":"WebSite","@id":"https:\/\/mybusinessfuture.com\/en\/#website","url":"https:\/\/mybusinessfuture.com\/en\/","name":"MyBusinessFuture","description":"B2B-Magazin f\u00fcr Digitalisierung, KI und Business-Innovation \u2014 Fachartikel f\u00fcr IT-Entscheider im DACH-Raum","publisher":{"@id":"https:\/\/mybusinessfuture.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mybusinessfuture.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mybusinessfuture.com\/en\/#organization","name":"MyBusinessFuture","url":"https:\/\/mybusinessfuture.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mybusinessfuture.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png","contentUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png","width":398,"height":241,"caption":"MyBusinessFuture"},"image":{"@id":"https:\/\/mybusinessfuture.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MyBusinessFuture","https:\/\/x.com\/mbusinessfuture","https:\/\/www.linkedin.com\/showcase\/mybusinessfuture\/"]},{"@type":"Person","@id":"https:\/\/mybusinessfuture.com\/en\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760","name":"Tobias Massow","description":"Tobias Massow ist Gesch\u00e4ftsf\u00fchrer der Evernine Media GmbH und Herausgeber von MyBusinessFuture. Er verantwortet die strategische Ausrichtung des Magazins und des gesamten MBF Media Netzwerks mit vier B2B-Fachmagazinen f\u00fcr IT-Entscheider im deutschsprachigen Raum.","sameAs":["https:\/\/www.linkedin.com\/in\/tobias-massow\/"],"url":"https:\/\/mybusinessfuture.com\/en\/experte\/tobias-evm\/"}]}},"_links":{"self":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts\/97757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/users\/205"}],"replies":[{"embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/comments?post=97757"}],"version-history":[{"count":8,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts\/97757\/revisions"}],"predecessor-version":[{"id":109445,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts\/97757\/revisions\/109445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/media\/92736"}],"wp:attachment":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/media?parent=97757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/categories?post=97757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/tags?post=97757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}